Bariatric Surgery Reduces Long-term Mortality in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease and Cirrhosis

Overview

Journal Clin Mol Hepatol

Specialty Gastroenterology

Date 2024 Nov 14

PMID 39541951

Authors

Nicholas A Rouillard

Scott D Barnett

Xinrong Zhang

Leslie Kam

Richie Manikat

Ramsey Cheung

Mindie H Nguyen

Affiliations

Soon will be listed here.

Abstract

Background/aims: With the obesity pandemic, metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease and a leading cause of end-stage liver disease and liver-related deaths in the USA. Therefore, we aimed to compare the long-term outcomes of patients with MASLD and cirrhosis with and without bariatric surgery.

Methods: Patients were retrospectively identified from the California Department of Healthcare Access and Information database, 2005 to 2019, for a population-based cohort study. Propensity score matching (PSM) was used to balance background risks between patients with cirrhosis who underwent bariatric surgery and those who did not. Overall, liver-related and non-liver-related mortality were analyzed.

Results: Of 91,708 eligible patients with MASLD and cirrhosis, PSM yielded 2,107 patients who underwent bariatric surgery and 8,428 non-bariatric controls. Compared to matched controls, patients who underwent bariatric surgery had lower 5-year overall (24.9% vs. 37.1%; p<0.0001), liver-related (3.3% vs. 14%; p<0.0001), and non-liver-related mortality (22.3% vs. 26.9%; p=0.046). In multivariable analysis, bariatric surgery was associated with decreased overall mortality (adjusted hazard ratio [aHR]=0.63; p<0.0001), liver-related (aHR=0.24; p<0.0001), and non-liverrelated (aHR=0.81; p=0.0026) mortality. However, only laparoscopic surgeries were associated with lower overall mortality (aHR=0.39; p<0.0001) whereas open surgeries were associated with higher overall mortality (aHR=1.24; p=0.022).

Conclusion: Patients with MASLD and cirrhosis who underwent bariatric surgery, specifically laparoscopic approaches, had significantly lower mortality risk than non-surgical counterparts.

References

Nor Hanipah Z, Punchai S, McCullough A, Dasarathy S, Brethauer S, Aminian A . Bariatric Surgery in Patients with Cirrhosis and Portal Hypertension. Obes Surg. 2018; 28(11):3431-3438. DOI: 10.1007/s11695-018-3372-z. View

Jan A, Narwaria M, Mahawar K . A Systematic Review of Bariatric Surgery in Patients with Liver Cirrhosis. Obes Surg. 2015; 25(8):1518-26. DOI: 10.1007/s11695-015-1727-2. View

Manzano-Nunez R, Rivera-Esteban J, Comas M, Angel M, Flores V, Banares J . Outcomes of Patients with Severe Obesity and Cirrhosis with Portal Hypertension Undergoing Bariatric Surgery: a Systematic Review. Obes Surg. 2022; 33(1):224-233. DOI: 10.1007/s11695-022-06362-9. View

Klein S, Mittendorfer B, Eagon J, Patterson B, Grant L, Feirt N . Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology. 2006; 130(6):1564-72. DOI: 10.1053/j.gastro.2006.01.042. View

Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

Lassailly G, Caiazzo R, Buob D, Pigeyre M, Verkindt H, Labreuche J . Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients. Gastroenterology. 2015; 149(2):379-88. DOI: 10.1053/j.gastro.2015.04.014. View

Izzy M, Angirekula M, Abu Dayyeh B, Bazerbachi F, Watt K . Bariatric surgery proves long-term benefit in patients with cirrhosis. Gastroenterol Rep (Oxf). 2021; 9(3):252-256. PMC: 8309677. DOI: 10.1093/gastro/goaa057. View

Krishnan A, Hadi Y, Alqahtani S, Woreta T, Fang W, Abunnaja S . Cardiovascular Outcomes and Mortality After Bariatric Surgery in Patients With Nonalcoholic Fatty Liver Disease and Obesity. JAMA Netw Open. 2023; 6(4):e237188. PMC: 10082402. DOI: 10.1001/jamanetworkopen.2023.7188. View

Verrastro O, Panunzi S, Castagneto-Gissey L, De Gaetano A, Lembo E, Capristo E . Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial. Lancet. 2023; 401(10390):1786-1797. DOI: 10.1016/S0140-6736(23)00634-7. View

10.

Mosko J, Nguyen G . Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol. 2011; 9(10):897-901. DOI: 10.1016/j.cgh.2011.07.007. View

11.

Wilson R, Lathigara D, Kaushal D . Systematic Review and Meta-Analysis of the Impact of Bariatric Surgery on Future Cancer Risk. Int J Mol Sci. 2023; 24(7). PMC: 10094585. DOI: 10.3390/ijms24076192. View

12.

Varela J, Wilson S, Nguyen N . Laparoscopic surgery significantly reduces surgical-site infections compared with open surgery. Surg Endosc. 2009; 24(2):270-6. DOI: 10.1007/s00464-009-0569-1. View

13.

Feng G, Han Y, Yang W, Shikora S, Mahawar K, Cheung T . Recompensation in MASLD-related cirrhosis via metabolic bariatric surgery. Trends Endocrinol Metab. 2024; 36(2):118-132. DOI: 10.1016/j.tem.2024.05.009. View

14.

Rausa E, Bonavina L, Asti E, Gaeta M, Ricci C . Rate of Death and Complications in Laparoscopic and Open Roux-en-Y Gastric Bypass. A Meta-analysis and Meta-regression Analysis on 69,494 Patients. Obes Surg. 2016; 26(8):1956-63. DOI: 10.1007/s11695-016-2231-z. View

15.

Mumtaz K, Lipshultz H, Jalil S, Porter K, Li N, Kelly S . Bariatric Surgery in Patients with Cirrhosis: Careful Patient and Surgery-Type Selection Is Key to Improving Outcomes. Obes Surg. 2020; 30(9):3444-3452. DOI: 10.1007/s11695-020-04583-4. View

16.

Flanagin A, Frey T, Christiansen S . Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals. JAMA. 2021; 326(7):621-627. DOI: 10.1001/jama.2021.13304. View

17.

Le M, Yeo Y, Li X, Li J, Zou B, Wu Y . 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2021; 20(12):2809-2817.e28. DOI: 10.1016/j.cgh.2021.12.002. View

18.

Imam A, Alim H, Binhussein M, Kabli A, Alhasnani H, Allehyani A . Weight Loss Effect of GLP-1 RAs With Endoscopic Bariatric Therapy and Bariatric Surgeries. J Endocr Soc. 2023; 7(12):bvad129. PMC: 10628815. DOI: 10.1210/jendso/bvad129. View

19.

Younus H, Sharma A, Miquel R, Quaglia A, Kanchustambam S, Carswell K . Bariatric Surgery in Cirrhotic Patients: Is It Safe?. Obes Surg. 2019; 30(4):1241-1248. DOI: 10.1007/s11695-019-04214-7. View

20.

Elhelw O, Ragavan S, Majeed W, Alkhaffaf B, Mohammed N, Senapati S . The impact of bariatric surgery on liver enzymes in people with obesity: A 5-year observational study. Surgeon. 2023; 22(1):e26-e33. DOI: 10.1016/j.surge.2023.07.006. View